Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Sterile Serological Pipette Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Sterile Serological Pipette Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 213 Pages
Report ld: 5343911
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Sterile Serological Pipette Market Size(US$)
CAGR 2025-2031
5.2%
Market Size,2031
USD 363
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 268 million
Market Forecast in 2031(Value)
US$ 363 million
CAGR
5.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Sterile Serological Pipette market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Scilogex
- Eppendorf
- Starlab
- VWR International
- CELLTREAT Scientific Products
- USA Scientific
- CAPP
- Globe Scientific
- Abdos Labtech
- SPL Life Sciences
- MIDSCI
- Thermo Fisher Scientific
- Tarsons
- Medline Industries
- Corning
- Greiner Bio-One
- Gilson
- Sartorius
- Bio-Rad Laboratories
- Nest Scientific
- Biologix
- TPP
- Sarstedt
- Merck
- Argos Technologies
- HiMedia
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 2 ml
- 5 ml
- 10 ml
- 25 ml
- Others
Segment by Application
- Cell Culture
- Bacteriology
- Clinical Research
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Sterile Serological Pipette study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Sterile Serological Pipette: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sterile Serological Pipette Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 2 ml
1.2.3 5 ml
1.2.4 10 ml
1.2.5 25 ml
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Sterile Serological Pipette Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cell Culture
1.3.3 Bacteriology
1.3.4 Clinical Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sterile Serological Pipette Revenue Estimates and Forecasts 2020-2031
2.2 Global Sterile Serological Pipette Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sterile Serological Pipette Sales Estimates and Forecasts 2020-2031
2.4 Global Sterile Serological Pipette Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sterile Serological Pipette Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sterile Serological Pipette Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 2 ml Market Size by Manufacturers
3.5.2 5 ml Market Size by Manufacturers
3.5.3 10 ml Market Size by Manufacturers
3.5.4 25 ml Market Size by Manufacturers
3.5.5 Others Market Size by Manufacturers
3.6 Global Sterile Serological Pipette Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sterile Serological Pipette Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Sterile Serological Pipette Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sterile Serological Pipette Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sterile Serological Pipette Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sterile Serological Pipette Sales and Revenue by Type (2020-2031)
6.4 North America Sterile Serological Pipette Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sterile Serological Pipette Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sterile Serological Pipette Sales and Revenue by Type (2020-2031)
7.4 Europe Sterile Serological Pipette Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sterile Serological Pipette Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sterile Serological Pipette Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Sterile Serological Pipette Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sterile Serological Pipette Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sterile Serological Pipette Sales and Revenue by Type (2020-2031)
9.4 Central and South America Sterile Serological Pipette Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sterile Serological Pipette Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sterile Serological Pipette Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Sterile Serological Pipette Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sterile Serological Pipette Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Scilogex
11.1.1 Scilogex Corporation Information
11.1.2 Scilogex Business Overview
11.1.3 Scilogex Sterile Serological Pipette Product Models, Descriptions and Specifications
11.1.4 Scilogex Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Scilogex Sterile Serological Pipette Sales by Product in 2024
11.1.6 Scilogex Sterile Serological Pipette Sales by Application in 2024
11.1.7 Scilogex Sterile Serological Pipette Sales by Geographic Area in 2024
11.1.8 Scilogex Sterile Serological Pipette SWOT Analysis
11.1.9 Scilogex Recent Developments
11.2 Eppendorf
11.2.1 Eppendorf Corporation Information
11.2.2 Eppendorf Business Overview
11.2.3 Eppendorf Sterile Serological Pipette Product Models, Descriptions and Specifications
11.2.4 Eppendorf Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Eppendorf Sterile Serological Pipette Sales by Product in 2024
11.2.6 Eppendorf Sterile Serological Pipette Sales by Application in 2024
11.2.7 Eppendorf Sterile Serological Pipette Sales by Geographic Area in 2024
11.2.8 Eppendorf Sterile Serological Pipette SWOT Analysis
11.2.9 Eppendorf Recent Developments
11.3 Starlab
11.3.1 Starlab Corporation Information
11.3.2 Starlab Business Overview
11.3.3 Starlab Sterile Serological Pipette Product Models, Descriptions and Specifications
11.3.4 Starlab Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Starlab Sterile Serological Pipette Sales by Product in 2024
11.3.6 Starlab Sterile Serological Pipette Sales by Application in 2024
11.3.7 Starlab Sterile Serological Pipette Sales by Geographic Area in 2024
11.3.8 Starlab Sterile Serological Pipette SWOT Analysis
11.3.9 Starlab Recent Developments
11.4 VWR International
11.4.1 VWR International Corporation Information
11.4.2 VWR International Business Overview
11.4.3 VWR International Sterile Serological Pipette Product Models, Descriptions and Specifications
11.4.4 VWR International Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 VWR International Sterile Serological Pipette Sales by Product in 2024
11.4.6 VWR International Sterile Serological Pipette Sales by Application in 2024
11.4.7 VWR International Sterile Serological Pipette Sales by Geographic Area in 2024
11.4.8 VWR International Sterile Serological Pipette SWOT Analysis
11.4.9 VWR International Recent Developments
11.5 CELLTREAT Scientific Products
11.5.1 CELLTREAT Scientific Products Corporation Information
11.5.2 CELLTREAT Scientific Products Business Overview
11.5.3 CELLTREAT Scientific Products Sterile Serological Pipette Product Models, Descriptions and Specifications
11.5.4 CELLTREAT Scientific Products Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 CELLTREAT Scientific Products Sterile Serological Pipette Sales by Product in 2024
11.5.6 CELLTREAT Scientific Products Sterile Serological Pipette Sales by Application in 2024
11.5.7 CELLTREAT Scientific Products Sterile Serological Pipette Sales by Geographic Area in 2024
11.5.8 CELLTREAT Scientific Products Sterile Serological Pipette SWOT Analysis
11.5.9 CELLTREAT Scientific Products Recent Developments
11.6 USA Scientific
11.6.1 USA Scientific Corporation Information
11.6.2 USA Scientific Business Overview
11.6.3 USA Scientific Sterile Serological Pipette Product Models, Descriptions and Specifications
11.6.4 USA Scientific Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 USA Scientific Recent Developments
11.7 CAPP
11.7.1 CAPP Corporation Information
11.7.2 CAPP Business Overview
11.7.3 CAPP Sterile Serological Pipette Product Models, Descriptions and Specifications
11.7.4 CAPP Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 CAPP Recent Developments
11.8 Globe Scientific
11.8.1 Globe Scientific Corporation Information
11.8.2 Globe Scientific Business Overview
11.8.3 Globe Scientific Sterile Serological Pipette Product Models, Descriptions and Specifications
11.8.4 Globe Scientific Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Globe Scientific Recent Developments
11.9 Abdos Labtech
11.9.1 Abdos Labtech Corporation Information
11.9.2 Abdos Labtech Business Overview
11.9.3 Abdos Labtech Sterile Serological Pipette Product Models, Descriptions and Specifications
11.9.4 Abdos Labtech Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Abdos Labtech Recent Developments
11.10 SPL Life Sciences
11.10.1 SPL Life Sciences Corporation Information
11.10.2 SPL Life Sciences Business Overview
11.10.3 SPL Life Sciences Sterile Serological Pipette Product Models, Descriptions and Specifications
11.10.4 SPL Life Sciences Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 SPL Life Sciences Recent Developments
11.11 MIDSCI
11.11.1 MIDSCI Corporation Information
11.11.2 MIDSCI Business Overview
11.11.3 MIDSCI Sterile Serological Pipette Product Models, Descriptions and Specifications
11.11.4 MIDSCI Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 MIDSCI Recent Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Corporation Information
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Sterile Serological Pipette Product Models, Descriptions and Specifications
11.12.4 Thermo Fisher Scientific Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Thermo Fisher Scientific Recent Developments
11.13 Tarsons
11.13.1 Tarsons Corporation Information
11.13.2 Tarsons Business Overview
11.13.3 Tarsons Sterile Serological Pipette Product Models, Descriptions and Specifications
11.13.4 Tarsons Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Tarsons Recent Developments
11.14 Medline Industries
11.14.1 Medline Industries Corporation Information
11.14.2 Medline Industries Business Overview
11.14.3 Medline Industries Sterile Serological Pipette Product Models, Descriptions and Specifications
11.14.4 Medline Industries Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Medline Industries Recent Developments
11.15 Corning
11.15.1 Corning Corporation Information
11.15.2 Corning Business Overview
11.15.3 Corning Sterile Serological Pipette Product Models, Descriptions and Specifications
11.15.4 Corning Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Corning Recent Developments
11.16 Greiner Bio-One
11.16.1 Greiner Bio-One Corporation Information
11.16.2 Greiner Bio-One Business Overview
11.16.3 Greiner Bio-One Sterile Serological Pipette Product Models, Descriptions and Specifications
11.16.4 Greiner Bio-One Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Greiner Bio-One Recent Developments
11.17 Gilson
11.17.1 Gilson Corporation Information
11.17.2 Gilson Business Overview
11.17.3 Gilson Sterile Serological Pipette Product Models, Descriptions and Specifications
11.17.4 Gilson Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Gilson Recent Developments
11.18 Sartorius
11.18.1 Sartorius Corporation Information
11.18.2 Sartorius Business Overview
11.18.3 Sartorius Sterile Serological Pipette Product Models, Descriptions and Specifications
11.18.4 Sartorius Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Sartorius Recent Developments
11.19 Bio-Rad Laboratories
11.19.1 Bio-Rad Laboratories Corporation Information
11.19.2 Bio-Rad Laboratories Business Overview
11.19.3 Bio-Rad Laboratories Sterile Serological Pipette Product Models, Descriptions and Specifications
11.19.4 Bio-Rad Laboratories Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Bio-Rad Laboratories Recent Developments
11.20 Nest Scientific
11.20.1 Nest Scientific Corporation Information
11.20.2 Nest Scientific Business Overview
11.20.3 Nest Scientific Sterile Serological Pipette Product Models, Descriptions and Specifications
11.20.4 Nest Scientific Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Nest Scientific Recent Developments
11.21 Biologix
11.21.1 Biologix Corporation Information
11.21.2 Biologix Business Overview
11.21.3 Biologix Sterile Serological Pipette Product Models, Descriptions and Specifications
11.21.4 Biologix Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Biologix Recent Developments
11.22 TPP
11.22.1 TPP Corporation Information
11.22.2 TPP Business Overview
11.22.3 TPP Sterile Serological Pipette Product Models, Descriptions and Specifications
11.22.4 TPP Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 TPP Recent Developments
11.23 Sarstedt
11.23.1 Sarstedt Corporation Information
11.23.2 Sarstedt Business Overview
11.23.3 Sarstedt Sterile Serological Pipette Product Models, Descriptions and Specifications
11.23.4 Sarstedt Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Sarstedt Recent Developments
11.24 Merck
11.24.1 Merck Corporation Information
11.24.2 Merck Business Overview
11.24.3 Merck Sterile Serological Pipette Product Models, Descriptions and Specifications
11.24.4 Merck Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 Merck Recent Developments
11.25 Argos Technologies
11.25.1 Argos Technologies Corporation Information
11.25.2 Argos Technologies Business Overview
11.25.3 Argos Technologies Sterile Serological Pipette Product Models, Descriptions and Specifications
11.25.4 Argos Technologies Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 Argos Technologies Recent Developments
11.26 HiMedia
11.26.1 HiMedia Corporation Information
11.26.2 HiMedia Business Overview
11.26.3 HiMedia Sterile Serological Pipette Product Models, Descriptions and Specifications
11.26.4 HiMedia Sterile Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.26.5 HiMedia Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sterile Serological Pipette Industry Chain
12.2 Sterile Serological Pipette Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sterile Serological Pipette Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sterile Serological Pipette Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sterile Serological Pipette Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sterile Serological Pipette Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Sterile Serological Pipette Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Sterile Serological Pipette Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Sterile Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Sterile Serological Pipette Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Sterile Serological Pipette Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Sterile Serological Pipette Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Sterile Serological Pipette Sales by Region (2020-2025) & (K Units)
Table 8. Global Sterile Serological Pipette Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Sterile Serological Pipette Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Sterile Serological Pipette Sales Share by Manufacturers (2020-2025)
Table 12. Global Sterile Serological Pipette Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Sterile Serological Pipette Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Sterile Serological Pipette by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Serological Pipette as of 2024)
Table 16. Global Sterile Serological Pipette Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Sterile Serological Pipette Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Sterile Serological Pipette Manufacturing Base and Headquarters
Table 19. Global Sterile Serological Pipette Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Sterile Serological Pipette Sales by Type (2020-2025) & (K Units)
Table 23. Global Sterile Serological Pipette Sales by Type (2026-2031) & (K Units)
Table 24. Global Sterile Serological Pipette Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Sterile Serological Pipette Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Sterile Serological Pipette ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Sterile Serological Pipette Sales by Application (2020-2025) & (K Units)
Table 29. Global Sterile Serological Pipette Sales by Application (2026-2031) & (K Units)
Table 30. Sterile Serological Pipette High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Sterile Serological Pipette Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Sterile Serological Pipette Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Sterile Serological Pipette ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Sterile Serological Pipette Growth Accelerators and Market Barriers
Table 37. North America Sterile Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Sterile Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Sterile Serological Pipette Growth Accelerators and Market Barriers
Table 40. Europe Sterile Serological Pipette Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Sterile Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Sterile Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Sterile Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Sterile Serological Pipette Growth Accelerators and Market Barriers
Table 45. Southeast Asia Sterile Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Sterile Serological Pipette Investment Opportunities and Key Challenges
Table 47. Central and South America Sterile Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Sterile Serological Pipette Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Sterile Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Scilogex Corporation Information
Table 51. Scilogex Description and Major Businesses
Table 52. Scilogex Product Models, Descriptions and Specifications
Table 53. Scilogex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Scilogex Sales Value Proportion by Product in 2024
Table 55. Scilogex Sales Value Proportion by Application in 2024
Table 56. Scilogex Sales Value Proportion by Geographic Area in 2024
Table 57. Scilogex Sterile Serological Pipette SWOT Analysis
Table 58. Scilogex Recent Developments
Table 59. Eppendorf Corporation Information
Table 60. Eppendorf Description and Major Businesses
Table 61. Eppendorf Product Models, Descriptions and Specifications
Table 62. Eppendorf Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Eppendorf Sales Value Proportion by Product in 2024
Table 64. Eppendorf Sales Value Proportion by Application in 2024
Table 65. Eppendorf Sales Value Proportion by Geographic Area in 2024
Table 66. Eppendorf Sterile Serological Pipette SWOT Analysis
Table 67. Eppendorf Recent Developments
Table 68. Starlab Corporation Information
Table 69. Starlab Description and Major Businesses
Table 70. Starlab Product Models, Descriptions and Specifications
Table 71. Starlab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Starlab Sales Value Proportion by Product in 2024
Table 73. Starlab Sales Value Proportion by Application in 2024
Table 74. Starlab Sales Value Proportion by Geographic Area in 2024
Table 75. Starlab Sterile Serological Pipette SWOT Analysis
Table 76. Starlab Recent Developments
Table 77. VWR International Corporation Information
Table 78. VWR International Description and Major Businesses
Table 79. VWR International Product Models, Descriptions and Specifications
Table 80. VWR International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. VWR International Sales Value Proportion by Product in 2024
Table 82. VWR International Sales Value Proportion by Application in 2024
Table 83. VWR International Sales Value Proportion by Geographic Area in 2024
Table 84. VWR International Sterile Serological Pipette SWOT Analysis
Table 85. VWR International Recent Developments
Table 86. CELLTREAT Scientific Products Corporation Information
Table 87. CELLTREAT Scientific Products Description and Major Businesses
Table 88. CELLTREAT Scientific Products Product Models, Descriptions and Specifications
Table 89. CELLTREAT Scientific Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. CELLTREAT Scientific Products Sales Value Proportion by Product in 2024
Table 91. CELLTREAT Scientific Products Sales Value Proportion by Application in 2024
Table 92. CELLTREAT Scientific Products Sales Value Proportion by Geographic Area in 2024
Table 93. CELLTREAT Scientific Products Sterile Serological Pipette SWOT Analysis
Table 94. CELLTREAT Scientific Products Recent Developments
Table 95. USA Scientific Corporation Information
Table 96. USA Scientific Description and Major Businesses
Table 97. USA Scientific Product Models, Descriptions and Specifications
Table 98. USA Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. USA Scientific Recent Developments
Table 100. CAPP Corporation Information
Table 101. CAPP Description and Major Businesses
Table 102. CAPP Product Models, Descriptions and Specifications
Table 103. CAPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. CAPP Recent Developments
Table 105. Globe Scientific Corporation Information
Table 106. Globe Scientific Description and Major Businesses
Table 107. Globe Scientific Product Models, Descriptions and Specifications
Table 108. Globe Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Globe Scientific Recent Developments
Table 110. Abdos Labtech Corporation Information
Table 111. Abdos Labtech Description and Major Businesses
Table 112. Abdos Labtech Product Models, Descriptions and Specifications
Table 113. Abdos Labtech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Abdos Labtech Recent Developments
Table 115. SPL Life Sciences Corporation Information
Table 116. SPL Life Sciences Description and Major Businesses
Table 117. SPL Life Sciences Product Models, Descriptions and Specifications
Table 118. SPL Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. SPL Life Sciences Recent Developments
Table 120. MIDSCI Corporation Information
Table 121. MIDSCI Description and Major Businesses
Table 122. MIDSCI Product Models, Descriptions and Specifications
Table 123. MIDSCI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. MIDSCI Recent Developments
Table 125. Thermo Fisher Scientific Corporation Information
Table 126. Thermo Fisher Scientific Description and Major Businesses
Table 127. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 128. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Thermo Fisher Scientific Recent Developments
Table 130. Tarsons Corporation Information
Table 131. Tarsons Description and Major Businesses
Table 132. Tarsons Product Models, Descriptions and Specifications
Table 133. Tarsons Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Tarsons Recent Developments
Table 135. Medline Industries Corporation Information
Table 136. Medline Industries Description and Major Businesses
Table 137. Medline Industries Product Models, Descriptions and Specifications
Table 138. Medline Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Medline Industries Recent Developments
Table 140. Corning Corporation Information
Table 141. Corning Description and Major Businesses
Table 142. Corning Product Models, Descriptions and Specifications
Table 143. Corning Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Corning Recent Developments
Table 145. Greiner Bio-One Corporation Information
Table 146. Greiner Bio-One Description and Major Businesses
Table 147. Greiner Bio-One Product Models, Descriptions and Specifications
Table 148. Greiner Bio-One Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Greiner Bio-One Recent Developments
Table 150. Gilson Corporation Information
Table 151. Gilson Description and Major Businesses
Table 152. Gilson Product Models, Descriptions and Specifications
Table 153. Gilson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Gilson Recent Developments
Table 155. Sartorius Corporation Information
Table 156. Sartorius Description and Major Businesses
Table 157. Sartorius Product Models, Descriptions and Specifications
Table 158. Sartorius Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Sartorius Recent Developments
Table 160. Bio-Rad Laboratories Corporation Information
Table 161. Bio-Rad Laboratories Description and Major Businesses
Table 162. Bio-Rad Laboratories Product Models, Descriptions and Specifications
Table 163. Bio-Rad Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Bio-Rad Laboratories Recent Developments
Table 165. Nest Scientific Corporation Information
Table 166. Nest Scientific Description and Major Businesses
Table 167. Nest Scientific Product Models, Descriptions and Specifications
Table 168. Nest Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Nest Scientific Recent Developments
Table 170. Biologix Corporation Information
Table 171. Biologix Description and Major Businesses
Table 172. Biologix Product Models, Descriptions and Specifications
Table 173. Biologix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Biologix Recent Developments
Table 175. TPP Corporation Information
Table 176. TPP Description and Major Businesses
Table 177. TPP Product Models, Descriptions and Specifications
Table 178. TPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. TPP Recent Developments
Table 180. Sarstedt Corporation Information
Table 181. Sarstedt Description and Major Businesses
Table 182. Sarstedt Product Models, Descriptions and Specifications
Table 183. Sarstedt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. Sarstedt Recent Developments
Table 185. Merck Corporation Information
Table 186. Merck Description and Major Businesses
Table 187. Merck Product Models, Descriptions and Specifications
Table 188. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 189. Merck Recent Developments
Table 190. Argos Technologies Corporation Information
Table 191. Argos Technologies Description and Major Businesses
Table 192. Argos Technologies Product Models, Descriptions and Specifications
Table 193. Argos Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 194. Argos Technologies Recent Developments
Table 195. HiMedia Corporation Information
Table 196. HiMedia Description and Major Businesses
Table 197. HiMedia Product Models, Descriptions and Specifications
Table 198. HiMedia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 199. HiMedia Recent Developments
Table 200. Key Raw Materials Distribution
Table 201. Raw Materials Key Suppliers
Table 202. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 203. Milestones in Production Technology Evolution
Table 204. Distributors List
Table 205. Market Trends and Market Evolution
Table 206. Market Drivers and Opportunities
Table 207. Market Challenges, Risks, and Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Sterile Serological Pipette Product Picture
Figure 2. Global Sterile Serological Pipette Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 2 ml Product Picture
Figure 4. 5 ml Product Picture
Figure 5. 10 ml Product Picture
Figure 6. 25 ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Sterile Serological Pipette Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Cell Culture
Figure 10. Bacteriology
Figure 11. Clinical Research
Figure 12. Others
Figure 13. Sterile Serological Pipette Report Years Considered
Figure 14. Global Sterile Serological Pipette Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 16. Global Sterile Serological Pipette Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Sterile Serological Pipette Revenue Market Share by Region (2020-2031)
Figure 18. Global Sterile Serological Pipette Sales (2020-2031) & (K Units)
Figure 19. Global Sterile Serological Pipette Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global Sterile Serological Pipette Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers Sterile Serological Pipette Sales Volume Market Share in 2024
Figure 22. Global Sterile Serological Pipette Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. 2 ml Revenue Market Share by Manufacturer in 2024
Figure 25. 5 ml Revenue Market Share by Manufacturer in 2024
Figure 26. 10 ml Revenue Market Share by Manufacturer in 2024
Figure 27. 25 ml Revenue Market Share by Manufacturer in 2024
Figure 28. Others Revenue Market Share by Manufacturer in 2024
Figure 29. Global Sterile Serological Pipette Sales Market Share by Type (2020-2031)
Figure 30. Global Sterile Serological Pipette Revenue Market Share by Type (2020-2031)
Figure 31. Global Sterile Serological Pipette Sales Market Share by Application (2020-2031)
Figure 32. Global Sterile Serological Pipette Revenue Market Share by Application (2020-2031)
Figure 33. North America Sterile Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 34. North America Sterile Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 35. North America Top 5 Manufacturers Sterile Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 36. North America Sterile Serological Pipette Sales Volume (K Units) by Type (2020- 2031)
Figure 37. North America Sterile Serological Pipette Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 38. North America Sterile Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 39. North America Sterile Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 40. US Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 41. Canada Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 42. Mexico Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 43. Europe Sterile Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 44. Europe Sterile Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Europe Top 5 Manufacturers Sterile Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 46. Europe Sterile Serological Pipette Sales Volume (K Units) by Type (2020-2031)
Figure 47. Europe Sterile Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 48. Europe Sterile Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 49. Europe Sterile Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 50. Germany Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 51. France Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 52. U.K. Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 53. Italy Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 54. Russia Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Sterile Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 56. Asia-Pacific Sterile Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Top 8 Manufacturers Sterile Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 58. Asia-Pacific Sterile Serological Pipette Sales Volume (K Units) by Type (2020- 2031)
Figure 59. Asia-Pacific Sterile Serological Pipette Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 60. Asia-Pacific Sterile Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 61. Asia-Pacific Sterile Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 62. Indonesia Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 63. Japan Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 64. South Korea Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 65. China Taiwan Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 66. India Sterile Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 67. Central and South America Sterile Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 68. Central and South America Sterile Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 69. Central and South America Top 5 Manufacturers Sterile Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 70. Central and South America Sterile Serological Pipette Sales Volume (K Units) by Type (2021-2031)
Figure 71. Central and South America Sterile Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 72. Central and South America Sterile Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 73. Central and South America Sterile Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 74. Brazil Sterile Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 75. Argentina Sterile Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 76. Middle East, and Africa Sterile Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 77. Middle East and Africa Sterile Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 78. Middle East and Africa Top 5 Manufacturers Sterile Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 79. Middle East and Africa Sterile Serological Pipette Sales Volume (K Units) by Type (2021-2031)
Figure 80. South America Sterile Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 81. Middle East and Africa Sterile Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 82. Middle East and Africa Sterile Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 83. GCC Countries Sterile Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 84. Turkey Sterile Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 85. Egypt Sterile Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 86. South Africa Sterile Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 87. Sterile Serological Pipette Industry Chain Mapping
Figure 88. Regional Sterile Serological Pipette Manufacturing Base Distribution (%)
Figure 89. Global Sterile Serological Pipette Production Market Share by Region (2020-2031)
Figure 90. Sterile Serological Pipette Production Process
Figure 91. Regional Sterile Serological Pipette Production Cost Structure
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.2% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Sterile Serological Pipette in 2025?
Which companies rank high in the global Sterile Serological Pipette market?
What is the annual compound growth rate of the global Sterile Serological Pipette market size from 2025 to 2031?
What was the global market size of Sterile Serological Pipette in 2031?
Related Reports
Sterile Serological Pipette- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 168
USD 3950.00
(Single User License)
Global Sterile Serological Pipette Market Research Report 2026
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 157
USD 2900.00
(Single User License)
Global Sterile Serological Pipette Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 128
USD 4250.00
(Single User License)
Sterile Serological Pipette- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 187
USD 3950.00
(Single User License)
Global Sterile Serological Pipette Market Research Report 2025
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-13
Pages: 120
USD 2900.00
(Single User License)
Global Sterile Serological Pipette Market Insights, Forecast to 2030
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published Date: 2024-04-26
Pages: 126
USD 4900.00
(Single User License)
Global Sterile Serological Pipette Market Research Report 2024
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 113
USD 2900.00
(Single User License)
Sterile Serological Pipette- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 168
USD 3950.00 (Single User License)Global Sterile Serological Pipette Market Research Report 2026
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 157
USD 2900.00 (Single User License)Global Sterile Serological Pipette Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 128
USD 4250.00 (Single User License)Sterile Serological Pipette- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 187
USD 3950.00 (Single User License)Global Sterile Serological Pipette Market Research Report 2025
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-13
Pages: 120
USD 2900.00 (Single User License)Global Sterile Serological Pipette Market Insights, Forecast to 2030
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published: 2024-04-26
Pages: 126
USD 4900.00 (Single User License)Global Sterile Serological Pipette Market Research Report 2024
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 113
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now